UB Paderborn / Katalog / Suche / in CDI

Is an 8‐week regimen of glecaprevir/pibrentasvir sufficient for all hepatitis C virus infected patients in the real‐world experience?

Journal of gastroenterology and hepatology, 2021-07, Vol.36 (7), p.1944-1952

2021

Volltextzugriff (PDF)

Digit ratios and hospitalization for COVID‐19: A test of the low‐androgen‐driven and high‐androgen‐driven theories of COVID‐19 severity

Andrology (Oxford), 2024-07

2024

Volltextzugriff (PDF)

Right-left digit ratios, a novel form of asymmetry: Patterns of instability in children and relationships to platelet counts and hospitalization in adults with COVID-19

Frontiers in public health, 2022-10, Vol.10, p.995025-995025

2022

Volltextzugriff (PDF)

Understanding Covid-19: Digit ratios and duration of oxygen therapy in hospitalized Covid-19 patients

Early human development, 2024-02, Vol.189, p.105940-105940, Article 105940

2024

Volltextzugriff (PDF)

Factors influencing the failure of interferon-free therapy for chronic hepatitis C: Data from the Polish EpiTer-2 cohort study

World journal of gastroenterology : WJG, 2021-05, Vol.27 (18), p.2177-2192

2021

Volltextzugriff (PDF)

Real‐world effectiveness and safety of direct‐acting antivirals in patients with cirrhosis and history of hepatic decompensation: Epi‐Ter2 Study

Liver international, 2021-08, Vol.41 (8), p.1789-1801

2021

Volltextzugriff (PDF)

Entecavir plus tenofovir combination therapy for chronic hepatitis B in patients with previous nucleos(t)ide treatment failure

Hepatology international, 2016-09, Vol.10 (5), p.779-788

2016

Volltextzugriff (PDF)

The efficacy of paritaprevir/ritonavir/ombitasvir+dasabuvir and ledipasvir/sofosbuvir is comparable in patients who failed interferon-based treatment with first generation protease inhibitors - a multicenter cohort study

BMC infectious diseases, 2018-11, Vol.18 (1), p.580-9, Article 580

2018

Volltextzugriff (PDF)

Non-sustained ventricular tachycardia during treatment of genotype 3 chronic hepatitis C - a case report

Polski merkuriusz lekarski, 2016-02, Vol.40 (236), p.94

2016

Volltextzugriff (PDF)

Autophagy in DNA damage response

International journal of molecular sciences, 2015-01, Vol.16 (2), p.2641-2662

2015

Volltextzugriff (PDF)

Reactive Oxygen Species and Mitochondrial DNA Damage and Repair in BCR-ABL1 Cells Resistant to Imatinib

BioResearch open access, 2015-07, Vol.4 (1), p.334-342

2015

Volltextzugriff (PDF)

Doxorubicin Differentially Induces Apoptosis, Expression of Mitochondrial Apoptosis-Related Genes, and Mitochondrial Potential in BCR-ABL1-Expressing Cells Sensitive and Resistant to Imatinib

BioMed research international, 2015-01, Vol.2015, p.673512-9

2015

Volltextzugriff (PDF)

Mitochondrial mutagenesis in BCR-ABL1-expressing cells sensitive and resistant to imatinib

Acta biochimica Polonica, 2016-01, Vol.63 (2), p.365

2016

Volltextzugriff (PDF)

99mTc-HEPIDA hepatic clearance as a diagnostic tool: usefulness of plasma and hepatic clearance for assessment of hepatic parenchyma performance

Nuclear medicine review. Central & Eastern Europe, 2003, Vol.6 (1), p.23-28

2003

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Is an 8‐week regimen of glecaprevir/pibrentasvir sufficient for all hepatitis C virus infected patients in the real‐world experience?

Real‐world experience with Grazoprevir/Elbasvir in the treatment of previously “difficult to treat” patients infected with hepatitis C virus genotype 1 and 4

Digit ratios and hospitalization for COVID‐19: A test of the low‐androgen‐driven and high‐androgen‐driven theories of COVID‐19 severity

Right-left digit ratios, a novel form of asymmetry: Patterns of instability in children and relationships to platelet counts and hospitalization in adults with COVID-19

Understanding Covid-19: Digit ratios and duration of oxygen therapy in hospitalized Covid-19 patients

Factors influencing the failure of interferon-free therapy for chronic hepatitis C: Data from the Polish EpiTer-2 cohort study

Real‐world effectiveness and safety of direct‐acting antivirals in patients with cirrhosis and history of hepatic decompensation: Epi‐Ter2 Study

Effectiveness and Safety of Pangenotypic Regimens in the Most Difficult to Treat Population of Genotype 3 HCV Infected Cirrhotics

Real-world direct-acting antiviral treatment in kidney transplant and hemodialysis patients: the EpiTer-2 multicenter observational study

Entecavir plus tenofovir combination therapy for chronic hepatitis B in patients with previous nucleos(t)ide treatment failure

The efficacy of paritaprevir/ritonavir/ombitasvir+dasabuvir and ledipasvir/sofosbuvir is comparable in patients who failed interferon-based treatment with first generation protease inhibitors - a multicenter cohort study

Interferon Free Therapy with and Without Ribavirin for Genotype 1 HCV Cirrhotic Patients in the Real World Experience

Non-sustained ventricular tachycardia during treatment of genotype 3 chronic hepatitis C - a case report

Autophagy in DNA damage response

Reactive Oxygen Species and Mitochondrial DNA Damage and Repair in BCR-ABL1 Cells Resistant to Imatinib

Doxorubicin Differentially Induces Apoptosis, Expression of Mitochondrial Apoptosis-Related Genes, and Mitochondrial Potential in BCR-ABL1-Expressing Cells Sensitive and Resistant to Imatinib

THU-185-Effectiveness and safety of DAA-based treatment of hepatitis C patients with severe and end stage chronic kidney diseases-EpiTer-2 database analysis

THU-197-Comparative effectiveness of 8 versus 12 weeks of ombitasvir/paritaprevir/ritonavir and dasabuvir in treatment-naive patients infected with HCV genotype 1b with non-advanced hepatic fibrosis

THU-140-Characteristics of patients and effectiveness of chronic hepatitis C treatment during the initial 4 years of access to interferon-free therapy

THU-217-Low risk of HBV reactivation in a large European cohort of HBV/ HCV coinfected patients treated with DAA

Mitochondrial mutagenesis in BCR-ABL1-expressing cells sensitive and resistant to imatinib

99mTc-HEPIDA hepatic clearance as a diagnostic tool: usefulness of plasma and hepatic clearance for assessment of hepatic parenchyma performance

Suchergebnisse filtern